Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Six-Year Trends in ICU Admission, Management, and Outcomes of Chimeric Antigen Receptor T-Cell Patients in the ICU.
Journal: Critical care medicine
Published: December 30, 2025
Novel Cancer Therapeutics: Perioperative Implications and Challenges.
Journal: Anesthesia and analgesia
Published: October 25, 2024
Management and Prevention of Cellular-Therapy-Related Toxicity: Early and Late Complications.
Journal: Current oncology (Toronto, Ont.)
Published: April 04, 2023
Indicators of Clinical Trajectory in Patients With Cancer Who Receive Cardiopulmonary Resuscitation.
Indicators of Clinical Trajectory in Patients With Cancer Who Receive Cardiopulmonary Resuscitation.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 18, 2022
Risk factors associated with development of coinfection in critically Ill patients with COVID-19.
Journal: Acute and critical care
Published: February 11, 2022
Surge capacity and capability of intensive care units across a large healthcare system: An operational blueprint for regional integration.
Journal: American journal of disaster medicine
Published: December 14, 2021
Critically Ill Patients Treated for Chimeric Antigen Receptor-Related Toxicity: A Multicenter Study.
Critically Ill Patients Treated for Chimeric Antigen Receptor-Related Toxicity: A Multicenter Study.
Journal: Critical care medicine
Published: July 14, 2021
A High Neutrophil-Lymphocyte Ratio Is Associated With Increased Morbidity and Mortality in Patients With Coronavirus Disease 2019.
Journal: Critical care explorations
Published: May 26, 2021
Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation.
Journal: European heart journal open
Published: April 11, 2021
Critically ill patients with severe immune checkpoint inhibitor related neurotoxicity: A multi-center case series.
Journal: Journal of critical care
Published: March 23, 2021
Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial.
Journal: The Lancet. Rheumatology
Published: March 23, 2021
Tocilizumab in Coronavirus Disease 2019-Related Critical Illness: A Propensity Matched Analysis.
Journal: Critical care explorations
Published: January 25, 2021
Last Updated: 09/26/2026